Related Experiment Video
Updated: Mar 27, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
A Multistep Computational Approach to Achieve a Complete Human 5-Lipoxygenase Structure and Provide a Pharmacophore
Lisa Lombardo1, Francesco Agnello1, Rosaria Gitto1
1Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, Messina, Italy.
Researchers developed a computational model of human 5-lipoxygenase (5-LOX) to aid in designing new inhibitors for diseases like asthma and cancer. This model provides a full-length open conformation for drug discovery.
Area of Science:
- Biochemistry
- Structural Biology
- Computational Chemistry
Background:
- Human 5-lipoxygenase (5-LOX) is vital for leukotriene (LT) synthesis.
- 5-LOX inhibitors are therapeutic candidates for asthma, cardiovascular diseases, allergies, and cancer.
- Existing 5-LOX crystal structures are incomplete, hindering inhibitor design.
Purpose of the Study:
- To computationally reconstruct the full-length open conformation of 5-LOX.
- To develop a structure-based pharmacophore model for novel inhibitor identification.
Main Methods:
- Computational procedure for 5-LOX structure reconstruction.
- Molecular dynamics simulations and protein model validation.
- Docking analyses and pharmacophore modeling.
Main Results:
- The first full-length open conformation of 5-LOX complexed with a chelating inhibitor was generated.
- Dynamic simulations and validation confirmed the model's quality.
- A structure-based pharmacophore model was successfully developed.
Conclusions:
- Computational methods can effectively reconstruct complex protein structures.
- The developed model and pharmacophore are valuable for designing novel 5-LOX inhibitors.
- This approach facilitates rational drug design for 5-LOX-related diseases.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacodynamic Models: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

